Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 Jan 1;183(1):329-34.
doi: 10.1084/jem.183.1.329.

Immunoglobulin-mediated signal transduction in B cells from CD45-deficient mice

Affiliations

Immunoglobulin-mediated signal transduction in B cells from CD45-deficient mice

T Benatar et al. J Exp Med. .

Abstract

CD45 expression is essential for immunoglobulin (Ig)-mediated B cell activation. Treatments with either anti-Ig or anti-CD45 suggest that CD45 may facilitate early signaling events such as calcium mobilization, and phosphoinositide hydrolyis as well as later events leading to transcription of genes such as c-myc. To examine the role of CD45 more extensively, CD45-deficient mice were generated by disruption of exon 6. Although normal numbers of B cells were found in peripheral lymphoid tissues, CD45-deficient cells failed to proliferate upon IgM crosslinking. In the present study, we demonstrate that the fraction of high buoyant density B cells is reduced while low buoyant density cells are increased. Moreover, there is a significant decline in the number of splenic B cells of the mature IgDhi, IgMlo phenotype. Although both the basal and anti-Ig-induced levels of phosphorylation of Ig-alpha and phospholipase C gamma 2 are indistinguishable from that observed in CD45+ control B cells, a major distinction was found in Ca2+ mobilization. While anti-Ig-induced mobilization of intracellular Ca2+ stores was normal, influx from extracellular sources was abrogated. This finding reveals a novel pathway of regulating B cell responses mediated by CD45.

PubMed Disclaimer

References

    1. Eur J Immunol. 1984 Aug;14(8):753-7 - PubMed
    1. Eur J Immunol. 1984 Nov;14(11):979-87 - PubMed
    1. J Immunol. 1987 May 15;138(10):3159-66 - PubMed
    1. J Immunol. 1989 Jun 15;142(12):4144-52 - PubMed
    1. Scand J Immunol. 1990 May;31(5):583-91 - PubMed

Publication types

MeSH terms